ICON (ICLR) Gains From New Offerings, Strategic Acquisitions

ICON plc’s (ICLR) focus on Patient Access & Engagement strategy and favorable CRO industry trends are major tailwinds. Strategic partnerships are an added positive. The stock carries a Zacks Rank #2 (Buy) currently.ICON is gaining from its focused patient, site and data strategy, which is helping it to improve site identification and study placement, patient recruitment and retention. In this regard, Accellacare, ICON's global clinical research network, is successfully offering customers a wide range of sta ...